EMA
- Status: approved
Oral P2Y12 receptor blocker (Oral P2Y12 receptor blocker) regulatory status in European Union.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA has authorised it.
Italian Society of Invasive Cardiology is the originator. The local marketing authorisation holder may differ — check the official source linked above.